{"pub": "investing.com", "url": "https://ph.investing.com/news/stock-market-news/day-ahead-top-3-things-to-watch-74142", "downloaded_at": "2019-10-28 23:39:32.875343+00:00", "title": "Day Ahead: Top 3 Things to Watch", "language": "en", "text": "\u00a9 Reuters.\n\nInvesting.com - Here's a preview of the top 3 things that could rock markets tomorrow.\n\n1. U.S. Consumer Confidence, Housing in Spotlight\n\nTop-tier economic data is on the calendar for tomorrow in the form of pending homes sales and consumer confidence.\n\nThe Conference Board will issue its measure of for October at 10:00 AM ET (14:00 GMT).\n\nThe index is expected to rise to 128 from 125.1 in September, according to economists\u2019 forecasts compiled by Investing.com.\n\nConsumer confidence data will take on added scrutiny after weaker retail sales data released last week raised concerns about consumer spending, which has been the main tailwind for the economy.\n\nAt the same time, the latest data on pending home sales, meanwhile, is slated for 10:00 AM ET as well. The report will come from the National Association of Realtors.\n\nOn average, economists predict that rose 0.9% in September, compared with a 1.6% increase in the previous month.\n\nThe duo of reports comes just a day ahead of the Federal Reserve's rate decision, with the odds of a cut to 1.5% to 1.75% at about 95%, up from 92% last week, according to Investing.com\u2019s .\n\n2. GM, Pfizer Earnings Due\n\nGeneral Motors (NYSE: ) and Pfizer (NYSE: ) roll up with earnings before the market opens tomorrow.\n\nThe automaker\u2019s earnings, however, are likely to take a back seat to commentary about how the 40-day of the UAW hurt business.\n\nThe strike, which involved about 50,000 workers at GM, is expected to have costed the company about $2 billion, according to Bank of America (NYSE: ).\n\nBeyond the impact of the strike, car sales will also be in focus with the company reporting earlier this month that it had sold 738,638 vehicles in the quarter, up 6.3% from a year earlier.\n\nGM is earnings $1.38 a share on revenue of $34.95 billion.\n\nIn pharma, Pfizer will be in the spotlight, with the drugmaker of 62 cents per share on revenue of $12.27 billion.\n\nThe company's share price has come under pressure amid valuation concerns, with Morgan Stanley (NYSE: ) saying the earnings power of Pfizer) and Upjohn, the off-patent drug business it spun off this year, are weaker than expected amid concerns about negative regulatory action and lower margins.\n\n3. AMD Earnings on Deck\n\nChip stocks will be in focus tomorrow as AMD reports earnings after the closing bell tomorrow.\n\nAdvanced Micro Devices (NASDAQ: ) reports earnings amid a favorable backdrop, following the launch of its new chips, which attracted notable customers like Alphabet (NASDAQ: ).\n\nThe earnings report comes as the company continues to scoop up new business at the lower end of the market, after Intel (NASDAQ: ) decided to de-prioritize shipments of low-end CPUs.\n\n\u201cIIntel's PC CPU shortages should again have allowed AMD to gain share at OEMs/ODMs who need to find substitutes for older/low end INTC parts,\u201d Wedbush said in a note to clients.\n\nIts gaming sector, which makes up the bulk of revenue, will likely get a boost from strong PC shipments, which should \u201chave boosted both AMD's CPU and GPU businesses in the quarter,\u201d Wedbush added.\n\nAMD is earnings of 18 cents per share on revenue of $1.81 billion.", "description": "Day Ahead: Top 3 Things to Watch", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB3F137_L.jpg", "published_at": "2019-10-28"}